http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19980032984-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-16 |
| filingDate | 1997-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19980032984-A |
| titleOfInvention | Substituted Benzyurea Derivatives and Pharmaceuticals Containing the Same |
| abstract | The present invention is represented by the following general formula (1)n n n n n n n n [Wherein, R 1 and R 2 each represent H, a halogen atom, an alkyl group or an alkoxy group, R 3 represents a phenyl or heterocyclic group which may have a substituent, n represents an integer of 1 to 6, and R 4 represents a substituent The substituted benzylurea derivative or its salt represented by] is represented by the phenyl group which may have the following, and the medicine which uses this as an active ingredient is provided. Since the compound of the present invention strongly inhibits only ACAT in macrophages, it is useful as an agent for preventing and treating atherosclerosis. |
| priorityDate | 1996-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.